Alkaloids of Nitraria sibirica Pall. decrease hypertension and albuminuria in angiotensin II-salt hypertension

• Published in: Chinese journal of natural medicines 2014-04, Vol.12 (4), p.266-272
• Main Authors: Bakri, Mahinur, YI, Yang, CHEN, Ling-Dan, Aisa, Haji Akber, WANG, Mong-Heng
• Format: Article
• Language: English
• Subjects: Albuminuria; Albuminuria - drug therapy; Albuminuria - metabolism; Albuminuria - physiopathology; Alkaloids; Alkaloids - administration & dosage; Angiotensin II - metabolism; Animals; Blood pressure; Blood Pressure - drug effects; Chemokine CCL2 - metabolism; Drugs, Chinese Herbal - administration & dosage; High salt diet; Humans; Hypertension; Hypertension - drug therapy; Hypertension - metabolism; Hypertension - physiopathology; Magnoliopsida - chemistry; Male; Mice; Nitraria sibirica; Rats, Sprague-Dawley; Sodium Chloride, Dietary - adverse effects; Sodium Chloride, Dietary - metabolism
• ISSN: 1875-5364; 1875-5364
• DOI: 10.1016/S1875-5364(14)60053-4

In traditional Chinese medicine, Nitraria sibirica Pall. (Nitrariaceae) is used to treat hypertension. This study determined the effects of the total alkaloids of the leaves of Nitraria sibirica (NSTA) on blood pressure and albuminuria in mice treated with angiotensin II and a high-salt diet (ANG/HS). Adult mice were divided into three groups: control; infused with angiotensin II and fed a diet containing 4% NaCl (ANG/HS; and ANG/HS plus injection of NSTA (1 mg·kg−1·d−1, i.p.). After treatment of these regimens, daily water and food intake, kidney weight, blood pressure, urinary albumin excretion, renal concentrations of inflammatory markers, including soluble intercellular adhesion molecule-1 (sICAM-1) and monocyte chemoattractant protein-1 (MCP-1), and the expression of renal fibrosis markers were determined. Compared to the control group, the ANG/HS group had higher blood pressure and urinary albumin excretion. Treatment with NSTA in ANG/HS mice for three weeks significantly reduced blood pressure and urinary albumin excretion. ANG/HS treatment caused elevated levels of sICAM-1 and MCP-1, as well as increased fibrosis markers. Concurrent treatment with ANG/HS and NSTA attenuated the levels and expression of renal inflammatory and fibrosis markers. Treatment with NSTA effectively reduces hypertension-induced albuminuria through the reduction of renal inflammatory and fibrosis markers.